Document is current
Any future updates will be listed below
-
Authors
Capdevila, Jaume https://orcid.org/0000-0003-0718-8619
Hernando, Jorge
Molina-Cerillo, Javier
Plana Serrahima, Maria https://orcid.org/0000-0003-3585-5247
Taberna Sanz, Miren
Castelo, Beatriz
Álvarez-Escolá, Cristina
Carmona-Bayonas, Alberto https://orcid.org/0000-0002-1930-9660
Ballester Navarro, Inmaculada
Iglesias, Lara
Bover, Mateo https://orcid.org/0000-0001-6628-3777
Garcia-Alvarez, Alejandro https://orcid.org/0000-0001-6948-0485
Lavernia, Javier
Yayá Tur, Ricardo
Ruiz, Sofia
Baste, Neus
Lorenzo-Lorenzo, Isabel
Sanchez-Hernandez, Alfredo https://orcid.org/0000-0001-5826-8390
Sanz-Garcia, Enrique https://orcid.org/0000-0002-3119-3832
Marquina, Gloria https://orcid.org/0000-0002-8961-9787
Nuciforo, Paolo https://orcid.org/0000-0003-1380-0990
Elguero, Belén
Grande, Enrique
Alonso-Gordoa, Teresa
-
Funding
Funding for this research was provided by:
AstraZeneca (NA)
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 13 March 2026
First Online: 4 April 2026
Competing interests
: The authors declare the following competing interests: A.G.A. declares speakers’ bureau from EISAI Europe and Lilly; and travel, accommodations and expenses from Advanz, EISAI, Ipsen, ADACAP (Novartis), Amgen, Pfizer, Lilly. M.P.S. declares honoraria and payment for travel/accommodations/expenses from Eisai Europe, Merck Serono, and MSD. C.A.E. declares honoraria as speaker fees, served on advisory boards, and received sponsorship and accommodation at scientific meetings from Astra Zeneca, IPSEN, Pfizer, Bayer, and MSD. T.A.G. declares fees for speakers, consultancy, research, and other nonfinancial support from IPSEN, Eli Lilly, Adacap, Pfizer, EISAI, Bayer, Johnson & Johnson, Astellas-Pharma, Roche, BMS, and MSD. A.C.B. declares research and speaking grants from Esteve, speaking grants from Lilly, and travel grants from MSD, Roche and Amgen. N.B. declares consulting honoraria from Merck Serono, Bristol-Myers Squibb, Lilly, and Eisai; and travel/accommodation expenses from Merck Serono. E.S.G. declares honoraria as a consultant for GSK and research grants (institution) from GSK and Rgenta Therapeutics. The remaining co-authors declare no competing interests regarding this study.
